Filter
811
Filtered Results: 811
Text search:
Ebola
preparedness
Featured
Recommendations
96
New Publications
284
Language
Document type
No document type
411
Studies & Reports
147
Guidelines
100
Strategic & Response Plan
55
Manuals
50
Fact sheets
22
Situation Updates
13
Training Material
9
Brochures
1
Resource Platforms
1
Online Courses
1
Videos
1
Countries / Regions
Sierra Leone
85
Liberia
83
Congo, Democratic Republic of
57
Guinea
54
Global
52
Nigeria
30
Uganda
28
South Sudan
27
Rwanda
25
Senegal
25
West and Central Africa
18
Mali
18
Burkina Faso
16
Côte d’Ivoire / Ivory Coast
16
Kenya
14
Africa
13
Ghana
12
Western and Central Europe
12
East and Southern Africa
12
Syria
9
Middle East and North Africa
9
Ethiopia
9
Togo
7
India
7
Guinea-Bissau
6
Latin America and the Carribbean
6
Russia
6
Yemen
6
Zambia
6
Nepal
5
Mozambique
5
Germany
5
Bangladesh
5
South Africa
5
Chad
5
Benin
4
Cameroon
4
Niger
4
Afghanistan
4
Burundi
4
USA
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Brazil
4
Central African Republic
4
Angola
4
Gambia
3
Haiti
3
Tanzania
3
South–East Asia Region
3
Myanmar / Burma
3
Thailand
2
Ukraine
2
Lesotho
2
Philippines
2
Western Pacific Region
2
Jamaica
2
Colombia
1
Mexico
1
China
1
Iran
1
Malawi
1
Mongolia
1
Mauritania
1
Asia
1
Venezuela
1
Cape Verde
1
Jordan
1
Saudi Arabia
1
Mauritius
1
Lebanon
1
Vietnam
1
Namibia
1
Sudan
1
Indonesia
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
206
Key Resources
60
Public Health
42
Clinical Guidelines
28
Women & Child Health
22
Pharmacy & Technologies
10
Capacity Building
8
Toolboxes
Ebola
241
COVID-19
177
Rapid Response
90
Planetary Health
28
Health Financing Toolbox
26
Conflict
24
Global Health Education
24
Caregiver
19
Mental Health
13
AMR
13
Natural Hazards
11
Disability
10
Refugee
9
HIV
9
Specific Hazards
7
TB
5
Pharmacy
5
Zika
5
NTDs
3
Polio
3
Cholera
1
NCDs
1
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
This document outlines PAHO’s regional priorities for the year 2023 to sustain and scale up health emergency and humanitarian assistance in the Americas, with a focus on five priority countries currently facing a prolonged humanitarian crisis and recovering from recent acute emergencies: Colombia,...
In Control: A Practical Handbook for Professionals Working in Health Emergencies Internationally RKI
The greatest risk to persons engaging in international medical emergency response is poor preparation.
The In Control handbook hopes to provide a remedy.
At the time of writing, we are living through the Coronavirus (COVID-19) pandemic, a health emergency that disregards physical borders, brin...
Background: Comparable estimates of health spending are crucial for the assessment of health systems and to optimally deploy health resources. The methods used to track health spending continue to evolve, but little is known about the distribution of spending across diseases. We developed improved e...
The COVID-19 pandemic has resulted in a double shock - health and economic. As of March 1, 2021, COVID-19 has cost more than 2.5 million lives and triggered an economic recession surpassing any economic downturn since World War II.
Part I of this paper explores the impact of this current macro-fisc...
The 2021 Financing for Sustainable Development Report responds to the request made by Member States to review the impact of the COVID-19 pandemic on nancing for sustainable development, and to propose recommendations to rebuild better. The report underlines the need for policy actions to ensure e e...
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
To assess the impact of the COVID-19 pandemic on health and HIV expenditure, UNAIDS carried out a modelling study on fiscal space for health and HIV. From a sample of 28 countries, three countries—the Democratic Republic of the Congo, Jamaica, and Lesotho—were selected to capture health and HIV ...
The International Rescue Committee (IRC) is a leading humanitarian agency dedicated to helping people whose lives have been shattered by conflict and disaster to survive, recover, and gain control of their future. Health comprises nearly half of IRC’s program portfolio globally and encompasses thr...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...
In 2006, the Special Session of African Union Health Ministers adopted the Maputo Plan of Action for implementing the Continental Policy Framework on sexual and reproductive health and rights (SRHR), which expired at the end of 2015. The goal was for all stakeholders and partners to join forces and ...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
At the end of 2023, WHO convened our first-ever annual WHO Stakeholder Review Conference for Prevention and Response to Sexual Misconduct. Aimed at joint learning and frank discussion on challenges faced in the achieving zero tolerance for all forms of sexual misconduct by aid workers, the Conferenc...
The key to a lasting world free of all forms of poliovirus lies in rapidly interrupting all remaining endemic transmission of WPV in the endemic areas of Pakistan and Afghanistan. This is the only way to ensure that such strains do not re-emerge globally through international spread. It lays the cor...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
